Pinned
@AmitaGuptaMD has spent more than a decade on a $70m trial to study a new TB drug, enrolling 6,000 participants in 13 countries. It might all have been for nothing.
That's because an NIH policy has abruptly cut off billions to trials abroad. For @Nature


